Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132468) titled 'Efficacy Evaluation and Safety Analysis of Esketamine in Prevention of Post-induction Hypotension in Patients Undergoing Bronchoscopy' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The peoples hospital of xuancheng city
Condition:
Post-induced hypotension
Intervention:
Control group:Use 0.1-0.2 µg/kg sufentanil as the induction protocol for the analgesic drug.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-17
Target Sample Size: Control group:38;Experimental group:38;
Countries of Recruitment:
China
To know more, vis...